Replies to post #1465 on Imprimis Pharmaceuticals Inc (IMMY)

[hang ten]

JC, at least Cardium paid Transdel a nice compliment on the way out:

"Cardium's business model is focused on the opportunistic acquisition of assets having the potential for significant upside valuation," noted Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium.

Shares could be an opportunistic acquisition right now... JMO;-)